Previous Article
FDA Expectations for Responding to Employees in Pharmaceutical Manufacturing Infected with COVID-19
FDA Expectations for Responding to Employees in Pharmaceutical Manufacturing Infected with COVID-19

Global manufacturers and regulators are facing new challenges during the SARS-CoV-2 pandemic to maintain su...

Next Article
Biosimilars in the time of COVID-19 and beyond
Biosimilars in the time of COVID-19 and beyond

Introduction The recent COVID-19 pandemic has triggered a race for pharmaceutical companies to repurpose...